CARDIOL THERAPEUTICS INC-
COMMON STOCK · CUSIP 00BHZT969
1
institutional holders
+0 vs Q1 2022
945.2k
shares reported held*
$1.6mreported value*
0 new
0 added
1 reduced
0 sold out
net sold ≈ $25.9k (-15.4k shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.69.
Trends to Q2 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2021 | 1 |
| Q2 2021 | 1 |
| Q3 2021 | 1 |
| Q4 2021 | 1 |
| Q1 2022 | 1 |
| Q2 2022 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2021 | 0 | 1 |
| Q3 2021 | 0 | 1 |
| Q4 2021 | 0 | 1 |
| Q1 2022 | 0 | 1 |
| Q2 2022 | 0 | 1 |
Biggest buyers
| None |
Biggest sellers
| AdvisorShares Investments LLC | Reduced | -15.4k |
Holders, Q2 2022
| Manager | Shares | Change |
|---|---|---|
| AdvisorShares Investments LLC 0.44% of their portfolio | 945.2k $1.6m | Reduced -15.4k |